July 16, 2021

Members of Congress request MOU extension

Sixteen members of the U.S. House of Representatives have sent a joint letter to Acting FDA Commissioner Janet Woodcock — a letter asking FDA to extend the deadline for signing the MOU with states on interstate shipments of compounded drugs.

The MOU is set to take effect October 27, and without an extension of that deadline, several states have indicated they cannot sign it. In states that don’t sign the MOU, federal law imposes on compounding pharmacies a five percent cap on out-of-state shipments — an outcome that could be catastrophic for patients who reply on compounded medications.

The letter from members of Congress follows similar requests of FDA from APC, APhA, NABP, NASPA, and NCPA.

We’re grateful to the following members of Congress for signing this week’s letter to FDA:

  • Henry Cuellar, Texas
  • Neal P. Dunn, MD, Fla.
  • Andy Biggs, Ariz.
  • Michael C. Burgess, MD, Texas
  • Earl L. “Buddy” Carter, Ga.
  • Warren Davidson, Ohio
  • Paul A. Gosar, DDS, Ariz.
  • H. Morgan Griffith, Va.
  • Diana Harshbarger, PharmD, La.
  • Jaime Herrera Beutler, Wash.
  • Ronny L. Jackson, MD, Texas
  • Markwayne Mullin, Okla.
  • Gary Palmer, Ala.
  • Scott Peters, Calif.
  • Mark Pocan, Wisc.
  • Chris Stewart, Utah

You can read the final, signed letter here.